PURINE NUCLEOTIDE MODULATION OF COMPLEX ASSEMBLY BETWEEN THE DROSOPHILA CACCC AND DRE, BINDING-PROTEINS IN RAS2 REGULATION

  • Authors:
    • A TAL
    • R VEALE
    • O SEGEV
  • View Affiliations

  • Published online on: October 1, 1994     https://doi.org/10.3892/ijo.5.4.925
  • Pages: 925-929
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Previous characterisation of the Drosophila ras2/rop bidirectional promoter regulatory mechanism revealed two DNA-binding protein factors. These were named DCF (Drosophila CACCC-binding Factor) and DREF (Drosophila Replication Related Element-binding Factor) respectively. A major protein complex consisting of these two transcription factors specifically binds the CACCC and DRE sites. In the present study we show that limited trypsin digestion of the major complex dissociates DCF and DREF, in the active conformation, able to bind the CACCC and DRE motifs. In addition, we show that DNA-binding activity of the DREF/DCF heterodimer is specifically inhibited by the presence of purine nucleotides, while that of the individual factors remains unaltered.

Related Articles

Journal Cover

October 1994
Volume 5 Issue 4

Print ISSN: 1019-6439
Online ISSN:1791-2423

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
TAL, A., VEALE, R., & SEGEV, O. (1994). PURINE NUCLEOTIDE MODULATION OF COMPLEX ASSEMBLY BETWEEN THE DROSOPHILA CACCC AND DRE, BINDING-PROTEINS IN RAS2 REGULATION. International Journal of Oncology, 5, 925-929. https://doi.org/10.3892/ijo.5.4.925
MLA
TAL, A., VEALE, R., SEGEV, O."PURINE NUCLEOTIDE MODULATION OF COMPLEX ASSEMBLY BETWEEN THE DROSOPHILA CACCC AND DRE, BINDING-PROTEINS IN RAS2 REGULATION". International Journal of Oncology 5.4 (1994): 925-929.
Chicago
TAL, A., VEALE, R., SEGEV, O."PURINE NUCLEOTIDE MODULATION OF COMPLEX ASSEMBLY BETWEEN THE DROSOPHILA CACCC AND DRE, BINDING-PROTEINS IN RAS2 REGULATION". International Journal of Oncology 5, no. 4 (1994): 925-929. https://doi.org/10.3892/ijo.5.4.925